Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review

Multidrug-resistant tuberculosis (MDR-TB) is an infectious disease caused by <i>Mycobacterium tuberculosis</i> which is resistant to at least isoniazid and rifampicin. This disease is a worldwide threat and complicates the control of tuberculosis (TB). Long treatment duration, a combination of sever...

全面介紹

書目詳細資料

Principais autores:	Rhea Veda Nugraha, Vycke Yunivita, Prayudi Santoso, Rob E. Aarnoutse, Rovina Ruslami
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2021-05-01
叢編:	Scientia Pharmaceutica
主題:	clofazimine MDR-TB efficacy safety tolerability
在線閱讀:	https://www.mdpi.com/2218-0532/89/2/19
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!